News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Financial Results Half Year Ended, 31 December 2021

2022 Announcements.Financial

16.02.2022

DNA Repair Communiqué I

2022 Announcements . Clinical . Newsletter

15.02.2022

CLINUVEL Expands DNA Repair Program with 2nd DNA Repair Study

2022 Announcements . Clinical . News

14.02.2022

Appendix 4C & Activity Report

2022 Announcements . Financial

31.01.2022

CLINUVEL Kommuniqué 1

2022 Announcements . Corporate . Newsletter

28.01.2022

CLINUVEL Communiqué 1

2022 Announcements . Corporate . Newsletter

27.01.2022

SCENESSE® continued in Germany

2022 Announcements . Clinical . News

24.01.2022

Change of Director’s Interest Notice

2022 Announcements . Financial . Regulatory

19.01.2022

Notification of Cessation of Securities

2022 Announcements . Financial . Regulatory

19.01.2022

CLINUVEL completes enrolment in world-first stroke study

2022 Announcements . Clinical . News

17.01.2022

CLINUVEL’S GROWTH AND EXPANSION – H.C. Wainwright Bioconnect Conference 2022

2022 Announcements . Corporate . Presentation

10.01.2022

Progress of CLINUVEL’s DNA Repair Program

2021 Announcements . Corporate

23.12.2021

Chair’s Letter to Shareholders

2021 Announcements . Corporate

21.12.2021

.

Go To Top